Yarwood has held senior positions including group president of sterile technologies at Catalent Pharma Solutions and president for Europe and Asia Pacific at Catalent.
A pharmacy graduate from Nottingham University, Yarwood gained a PhD from Manchester University and an MBA from Warwick University before pursuing a career in the pharmaceutical industry.
Penn has also appointed David Cooper as operations director. Previously general manager of oral technologies at Zydis, Cooper also has extensive experience in global manufacturing, gained from Mylan Pharmaceuticals, formerly Merck Generics.
Mark Molyneux, chairman of Penn Pharmaceutical Services, said: ‘Both Richard and David will be valuable additions to our board of directors, and their appointments mark another important step as the company rolls out a £12m expansion programme over the next five years.’
Penn Pharma was established more than 30 years ago and since then has provided integrated drug development, clinical trial supply and manufacturing services to the healthcare industry.
You may also like
Manufacturing
PCI Pharma Services commences installation of sterile fill-finish and lyophilisation line
The Bedford, NH site will advance PCI's manufacturing capabilities with twin lyophilisers and a large-scale isolator filling line, making this the third sterile fill-finish facility built in the last three years
Manufacturing
Aldena Therapeutics selects PCI Pharma Services to manufacture and distribute innovative investigational treatment for dermatological diseases
World-leading CDMO offers highly specialised experience bringing complex formulations to market quickly and will support clinical trials of Aldena's siRNA-based injectable treatment
